National Bank of Canada FI raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 1,124.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 535,950 shares of the company’s stock after purchasing an additional 492,181 shares during the quarter. National Bank of Canada FI’s holdings in Henry Schein were worth $39,071,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Cromwell Holdings LLC grew its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Summit Securities Group LLC acquired a new position in shares of Henry Schein in the 2nd quarter valued at $31,000. Blue Trust Inc. grew its holdings in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the period. Farther Finance Advisors LLC increased its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its stake in Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after buying an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the company. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Finally, Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Seven equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $78.89.
Henry Schein Trading Up 0.7 %
Shares of NASDAQ:HSIC opened at $73.00 on Monday. The company has a 50-day simple moving average of $71.78 and a 200 day simple moving average of $69.89. The company has a market capitalization of $9.10 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 2.14 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the firm earned $1.32 EPS. The firm’s revenue was up .4% compared to the same quarter last year. Sell-side analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.
Insider Buying and Selling at Henry Schein
In other news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Guidewire Software Provides Long-Awaited Buying Opportunity
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Fast-Growing Companies That Are Still Undervalued
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.